ESR1 and invasive carcinoma: MtF people undergoing long-term estrogen-based hormone therapy may develop estrogen receptor–positive (ER +) breast tumors, with 21 non-implant-associated breast cancer cases reported since 1968, mostly invasive carcinomas.